Glen Harbor Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	$1.33M	Buy	14,756 +364	+3%	+$32.8K	0.03%	407
2019 Q2	$1.22M	Buy	14,392 +8,456	+142%	+$714K	0.03%	429
2019 Q1	$523K	Buy	5,936 +1,400	+31%	+$123K	0.01%	658
2018 Q4	$324K	Buy	+4,536	New	+$324K	0.01%	773